Effect of step-synchronized vibration stimulation of soles on gait in Parkinson's disease: a pilot study
© Novak and Novak; licensee BioMed Central Ltd. 2006
Received: 07 June 2005
Accepted: 04 May 2006
Published: 04 May 2006
Previous studies have suggested that impaired proprioceptive processing in the striatum may contribute to abnormal gait in Parkinson's disease (PD).
This pilot study assessed the effects of enhanced proprioceptive feedback using step-synchronized vibration stimulation of the soles (S-VS) on gait in PD. S-VS was used in 8 PD subjects (3 women and 5 men, age range 44–79 years, on medication) and 8 age-matched healthy subjects (5 women and 3 men). PD subjects had mild or moderate gait impairment associated with abnormal balance, but they did not have gait freezing. Three vibratory devices (VDs) were embedded in elastic insoles (one below the heel and two below the forefoot areas) inserted into the shoes. Each VD operates independently and has a pressure switch that activates the underlying vibratory actuator. The VD delivered the 70-Hz suprathreshold vibration pulse upon touch by the heel or forefoot, and the vibration pulse was deactivated upon respective push-offs. Six-minute hallway walking was studied with and without S-VS. Gait characteristics were measured using the force-sensitive foot switches. The primary outcome was the stride variability expressed as a coefficient of variation (CV), a measure of gait steadiness. Secondary outcome measures were walking distance and speed, stride length and duration, cadence, stance, swing and double support duration, and respective CVs (if applicable).
The walking speed (p < 0.04) and the CV of the stride interval (p < 0.02) differed between the groups and S-VS conditions. In the PD group, S-VS decreased stride variability (p < 0.002), increased walking speed (p < 0.0001), stride duration (p < 0.01), stride length (p < 0.0002), and cadence (p < 0.03). In the control group, S-VS decreased stride variability (p < 0.006) and increased gait speed (p < 0.03), but other locomotion parameters were not significantly altered.
Augmented sensory feedback improves parkinsonian gait steadiness in the short-term setting. Because the suprathreshold stimulation prevented blinding of subjects, the learning effect and increased attention can be a confounding factor underlying results. Long-term studies are needed to establish the clinical value of the S-VS.
Parkinson's disease (PD) is caused by a dopamine deficiency in the basal ganglia that results in characteristic motor abnormalities including postural instability and gait impairment. Short shuffling steps, slow walking speed, and increased stride variability characterize abnormal gait in PD. Although PD is primarily a motor disease, accumulating evidence suggests that abnormal proprioception and kinesthesia contribute to the parkinsonian gait. PD patients have reduced sensation on the plantar feet  and impaired joint position sense , movement perception , and movement accuracy [4–6]. It has been proposed that an inadequate integration of sensory inputs at the striatum and a defective proprioceptive feedback underlie abnormal motor control movement in PD [6, 7].
Sensory feedback is necessary for postural adjustments and facilitates control of compensatory stepping reactions evoked by postural perturbation [8–10]. Cutaneous, joint, and muscular mechanoreceptors provide the necessary proprioceptive inputs . Mechanical stimulation of foot mechanoreceptors can be used to perturb the proprioceptive feedback and to assess its role in generation of parkinsonian gait. The foot pressure activates the plantar mechanoreceptors that mediate postural adjustment during the stance phases of the step . Several studies explored the effects of mechanical stimulation upon static balance as a mean for proprioceptive feedback modulation. Subsensory mechanical noise applied to the soles has improved the quiet-standing balance in healthy controls  and in patients with diabetes and stroke . This effect was attributed to enhanced proprioceptive feedback. The effect of the suprathreshold stimulation is complex and depends on the frequency, amplitude, and location of the stimulation [14, 15]. For example, during standing, the vibratory stimulation of the forefoot zones induces early electromyographic responses in the soleus muscle (mean latency 119 ms), followed by small forward center of pressure (CoP) displacement (mean latency 251 ms) and backward body tilt (mean latency 434 ms). Vibratory stimulation of rear foot zones has a similar effect but with an opposite direction of the body tilt. Simultaneous activation of both forefoot and rear foot zones has no effect on body tilt but does cause CoP oscillations. These results imply that characteristic postural responses may be specific to the localization and character of a stimulus.
We hypothesized that a vibration stimulation of foot mechanoreceptors synchronized with the step improves gait in PD. In this study the step-synchronized vibration stimulation was used to enhance the proprioceptive input during walking in healthy and PD subjects. The vibratory stimulus was delivered to the soles during the stance phase of the step, but not during the swing phase. Preliminary results were previously published as an abstract .
Materials and methods
Demographic and clinical characteristics of subjects with Parkinson's disease
Unified Parkinson Disease Rating Scale
Subjects were included if they were able to walk for 6 minutes at self-paced speed without interruption. Subjects were excluded if they had medical history of peripheral polyneuropathy, hypertension, stroke, CNS or gait disorder, or diabetes or if they used walking aids. All healthy subjects had normal gait. The Institutional Review Board of Boston University approved the study, and all subjects signed a written informed consent.
The foot sensor that provides feedback to the VD is based on an industrial membrane switch that turns on with the force 350 g (Nelson Nameplate, Inc., Los Angeles, CA). The foot sensor is attached on top of the vibration motor enclosure. The VD (e.g., vibratory motor + membrane switch) is embedded in the elastic insoles (Dr. Scholl's massaging gel insoles®, Shering-Plough, Kenilworth, NJ). The VD is isolated from the shoe by shock-absorbing elastic silicon polymer. Each VD is activated independently, i.e., the heel switch controls the heel vibratory motor such that heel stimulation starts with heel touch and stops upon heel off. The forefoot switches control the underlying forefoot actuators that turn on upon forefoot touch and turn off upon toes lifting. This means that different parts of the sole are stimulated at different sub-phases of the step.
The walking trials were done in the on medication state in PD subjects. The insoles with VDs were inserted into the subject's shoes. Subjects walked for 6 minutes (6-minute walk test, ) at a self-paced speed in the hallway (length 73 m, width 1.7 m) with the VD turned off, and then they had a 5-minute sitting rest. Next, subjects walked for 6 minutes with the VD turned on. Subjects were not informed about the outcome measures. They were asked to walk comfortably at their normal walking speed, and they were specifically instructed not to walk faster or slower than their most comfortable level. All PD subjects were well familiar with the test place, where they had walked several times before. Any encouragement throughout the walking trials was avoided since it might affect the gait profile . To reduce expectation bias, subjects were allowed to walk for about 1 minute with the device on and off before the gait recordings. An investigator followed the study subjects during walking trials as a safety measure, and he also measured the gait distance with a "Meter-Man" distance-measuring wheel (Winnebago, MN).
Data Acquisition and Processing
Gait signals were recorded using the Gait Logger (JAS Research. Inc., Boston, MA) connected to the foot switches with 4 force sensors on each foot (B&L Engineering, Inc., Tustin, CA). Gait signals were sampled at 200 Hz per switch using a 16-bit analog/digital converter and recorded on the portable microcontroller-based storage device. The raw data were processed off-line using the software written in Matlab® 6.1 (The MathWorks, Inc., Natick, MA). Turns were excluded from statistical analysis since gait variability can be affected by a particular turning pattern (e.g., turning in a small circle versus sudden 180 degree rotation). Stride, stance, swing, and double support duration were computed in each gait cycle (in milliseconds and as a percentage of the gait cycle) and averaged over each walking trial. The primary outcome measure was the stride variability expressed as the coefficient of variation (CV) of the stride interval, which is a measure of gait steadiness . Secondary outcome measures were the following gait parameters: walking distance and speed, stride length and duration, cadence, stance, swing duration, double support, and their respective CVs (if applicable). Gait parameters were averaged between the right and left legs for statistical analysis.
Statistical analysis was performed using statistical software JPM 5.1 (SAS Institute, Cary, NC). The effects of vibratory stimulation between the conditions (S-VS on vs. S-VS off) and groups were compared using MANOVA adjusting for age, sex, and height. Paired t-test was used to compare effects of vibratory stimulation within each group.
Demographic characteristics (age, height, and weight) did not differ between the PD and the control groups.
Walking without step-synchronized vibration stimulation
Gait characteristics in the Parkinson's disease and control groups during 6-minute walking with and without step-synchronized vibration stimulation
Parkinson's Disease Group
Walking distance (m)
368 ± 73.4
402.7 ± 72.6
453.1 ± 53.2
476.1 ± 61.6
1.02 ± 0.2
1.11 ± 0.2
1.25 ± 0.2
1.32 ± 0.17
104.9 ± 8.9
109.2 ± 10.2
110.9 ± 4.9
112 ± 5.7
Stride duration (ms)
1149.6 ± 90.9
1107 ± 100.9
1112.9 ± 99.0
1103.2 ± 105.4
Stride length (m)
1.17 ± 0.24
1.24 ± 0.3
1.4 ± 0.16
1.37 ± 0.19
Stride CV (%)
5.36 ± 3.1
4.4 ± 2.7
2.8 ± 0.4
2.3 ± 0.5
Stance duration (ms)
730.8 ± 79.7
679.3 ± 90.2
653.8 ± 66.19
654.95 ± 69.9
Stance CV (%)
1.99 ± 1.0
1.6 ± 0.8
1.29 ± 0.63
0.99 ± 0.30
Swing duration (ms)
418.8 ± 54.8
427.7 ± 64.6
446.6 ± 83.4
435.8 ± 85.8
Swing CV (%)
1.86 ± 1.04
1.6 ± 0.8
0.95 ± 0.4
0.88 ± 0.45
Double support duration (ms)
156.0 ± 51.1
134.6 ± 42.8
115.6 ± 25.7
112.1 ± 45.7
Double support CV (%)
2.78 ± 1.6
2.77 ± 1.7
0.72 ± 0.25
0.97 ± 0.87
Step-synchronized vibration stimulation
The vibratory device was well tolerated; none of the subjects experienced gait freezing or falls. The most common experience was an increased awareness of the foot placement on the floor. The walking speed (p < 0.04) and the CV of the stride interval (p < 0.02) differed between the groups and between the S-VS on and S-VS off conditions (Table 2). The walking speed increased and the CV of the stride interval decreased during the S-VS on walking as compared to the S-VS off walking. Other locomotor parameters (cadence, stride, and swing duration) did not differ significantly either between groups or between S-VS conditions. There were no significant differences between the left and right legs in the stride interval and its corresponding CV.
Parkinson's disease group
The walking speed increased (p = 0.03) and the CV of the stride interval decreased (p = 0.006) during the S-VS walking. Other locomotion parameters were not significantly altered by the S-VS.
In this study, vibration stimulation of the foot soles synchronized with the step increased the walking speed and improved the stride variability in PD subjects. In addition, vibration stimulation prolonged the stride interval and the stride length. Stride variability also decreased in the control group. Stride variability, which is an important measure of motor performance and gait unsteadiness, is increased in subjects with a history of falls [19–23] and is an independent predictor of falling . The step-synchronized vibration may stabilize gait in PD patients by reducing the stride variability.
The vibration stimulus was suprathreshold, a situation that prevented blinding of the study participants. The increased awareness of foot placement may affect gait characteristics, as suggested by the effects of attention strategies . The subjects were instructed to walk at a comfortable speed without any reference to gait attention to minimize the unspecific effects of gait awareness. Therefore, it is not likely that increased attention may account for all S-VS effects.
In our study, subjects were walking at a comfortable pace, without any encouragement or instructions might affect their walking speed. The mean walking distance increased by 9.4% in the PD group and by 5.2% in the control group during the S-VS walking. The 6-minute walking test (6MWT) is believed to reflect activities of daily living, but there might be a placebo response and training effect among repetitive walking trials [18, 25]. For example, one study found an 8% increase in walking distance on the second trial in healthy elderly (2.5-hour break between the trials); another found a 3% increase in patients with fibromyalgia (1-day break between the trials) ; and a third found a 4.8% increase in patients with heart failure (30 minute break between the trials) . Direct comparisons of these repetitive walking trials are problematic, as the methodology differed among them. For example, subjects were asked to "walk a pace that was brisk but comfortable" without encouragement , to "cover as much distance as possible until exhausted" without encouragement , or to walk at their own maximal pace with encouragement every 30 seconds . Furthermore, the stride variability in repetitive 6MWT was not measured, and the effects of repetitive 6MWT trials on walking distance in PD patients are unknown. Our study differs from the above trials not only in terms of the patient population, the much shorter inter-trial breaks, and the lack of encouragement, but also in the fact that we took several measures to minimize the learning effect. These measures included walking in a familiar environment (PD group), using specific instructions to discourage subjects to walk faster (or slower) than at their most comfortable speed, and having each subject walk for as long as 1 minute with the vibratory devices turned on and off before the actual walking recordings. Nevertheless, as the placebo and learning effect cannot be completely excluded, only a long-term study in a larger patient population can provide robust measures of the effects of S-VS walking.
The effect of S-VS is likely to be related to enhanced proprioceptive feedback, even upon considering other possible confounders. Locomotor patterns are regulated through the feedback loops among the proprioceptive receptors and central motor pattern generators. Sensory feedback is necessary for gait stability in that it provides inputs to the central pattern generators that can instantly adapt to external perturbations and correct programming errors in intended movement direction, force, and execution [29–31]. The vibration device in our study operated in a simple closed loop mode wherein the enhanced feedback was synchronized with the distribution of plantar pressures during the gait cycle phase. Therefore, the synchronization of vibration stimulation with the gait phase may improve timing and variability of the gait cycle by enhanced recruitment of sensorimotor pathways including spinal circuitry and basal ganglia. Supporting this notion are functional magnetic resonance imaging studies that have demonstrated activation of distinct brain structures when vibration stimulus was used [32, 33]. Stimulation of the fingertips activated the contralateral primary somatosensory cortex, bilateral secondary somatosensory cortex, the precentral gyrus, the posterior insula, the posterior parietal region, and the posterior cingulate . Positron emission tomography studies showed that stimulation of the metacarpal joints activated ipsilateral sensory cortical areas and contralateral basal ganglia .
Results of this study, however, may be not applied to the whole PD population given our small sample and selection of patients. The PD subjects had mild to moderate gait impairment that was predominantly associated with abnormal balance. None of the subjects had the gait freezing episodes commonly seen in more advanced disease. Gait freezing is a poorly understood phenomenon that may be due to pathophysiological mechanisms different from those causing abnormal balance .
This study indicates that the step-synchronized vibration stimulation of the soles improves gait steadiness in Parkinson's disease patients with predominant balance impairment. The suprathreshold stimulation improved gait, presumably by enhancing the sensory feedback. Previous reports showing impaired proprioception support this notion. In this short-term non-blinded design, possible placebo and learning effects cannot be completely excluded. Long-term studies are needed to establish a clinical value of the S-VS.
step-synchronized vibration stimulation
coefficient of variation
center of pressure
Unified Parkinson Disease Rating Scale
6-minute walking test
levodopa equivalent scale
This study was sponsored by The Older American Independence Center Grant 2P60 AG08812-11.
- Pratorius B, Kimmeskamp S, Milani TL: The sensitivity of the sole of the foot in patients with Morbus Parkinson. Neurosci Lett 2003, 346: 173-176. 10.1016/S0304-3940(03)00582-2View ArticlePubMedGoogle Scholar
- Zia S, Cody F, O'Boyle D: Joint position sense is impaired by Parkinson's disease. Ann Neurol 2000, 47: 218-228. Publisher Full Text 10.1002/1531-8249(200002)47:2<218::AID-ANA12>3.0.CO;2-#View ArticlePubMedGoogle Scholar
- Schneider JS, Diamond SG, Markham CH: Parkinson's disease: sensory and motor problems in arms and hands. Neurology 1987, 37: 951-956.View ArticlePubMedGoogle Scholar
- Dietz V: Proprioception and locomotor disorders. Nat Rev Neurosci 2002, 3: 781-790. 10.1038/nrn939View ArticlePubMedGoogle Scholar
- Zia S, Cody F, O'Boyle D: Joint position sense is impaired by Parkinson's disease. Clin Anat 2002, 15: 23-31. 10.1002/ca.1087View ArticlePubMedGoogle Scholar
- Abbruzzese G, Berardelli A: Sensorimotor integration in movement disorders. Mov Disord 2003, 18: 231-240. 10.1002/mds.10327View ArticlePubMedGoogle Scholar
- Lewis GN, Byblow WD: Altered sensorimotor integration in Parkinson's disease. Brain 2002, 125: 2089-2099. 10.1093/brain/awf200View ArticlePubMedGoogle Scholar
- Park S, Horak FB, Kuo AD: Postural feedback responses scale with biomechanical constraints in human standing. Exp Brain Res 2004, 154: 417-427. 10.1007/s00221-003-1674-3View ArticlePubMedGoogle Scholar
- Zehr EP, Duysens J: Regulation of arm and leg movement during human locomotion. Neuroscientist 2004, 10: 347-361. 10.1177/1073858404264680View ArticlePubMedGoogle Scholar
- Maki BE, McIlroy WE: Postural control in the older adult. Clin Geriatr Med 1996, 12: 635-658.PubMedGoogle Scholar
- Tropp H, Commentary: Functional ankle instability revisited. J Athl Train 2002, 37: 512-515.PubMed CentralPubMedGoogle Scholar
- Priplata AA, Niemi JB, Harry JD, Lipsitz LA, Collins JJ: Vibrating insoles and balance control in elderly people. Lancet 2003, 362: 1123-1124. 10.1016/S0140-6736(03)14470-4View ArticlePubMedGoogle Scholar
- Priplata AA, Patritti BL, Niemi JB, Hughes R, Gravelle DC, Lipsitz LA, Veves A, Stein J, Bonato P, Collins JJ: Noise-enhanced balance control in patients with diabetes and patients with stroke. Ann Neurol 2006, 59: 4-12. 10.1002/ana.20670View ArticlePubMedGoogle Scholar
- Kavounoudias A, Roll R, Roll JP: Specific whole-body shifts induced by frequency-modulated vibrations of human plantar soles. Neurosci Lett 1999, 266: 181-184. 10.1016/S0304-3940(99)00302-XView ArticlePubMedGoogle Scholar
- Kavounoudias A, Roll R, Roll JP: Foot sole and ankle muscle inputs contribute jointly to human erect posture regulation. J Physiol 2001, 532: 869-878. 10.1111/j.1469-7793.2001.0869e.xPubMed CentralView ArticlePubMedGoogle Scholar
- Novak P, Novak V: Short term effects of vibratory stimulation of the soles synchronized with the step on gait in Parkinson's disease. Movement Disorders 2004, 19: 1129-1130. [Abstract]Google Scholar
- Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55: 181-184.PubMed CentralView ArticlePubMedGoogle Scholar
- Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JGF: Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. European Heart Journal 2005, 26: 778-793. 10.1093/eurheartj/ehi162View ArticlePubMedGoogle Scholar
- Maki BE: Gait changes in older adults: predictors of falls or indictors of fear. J Am Geriatr Soc 1997, 45: 313-320.View ArticlePubMedGoogle Scholar
- Nakamura T, Meguro K, Sasaki H: Relationship between falls and stride length variability in senile dementia of the Alzheimer type. Gerontology 1996, 42: 108-113.View ArticlePubMedGoogle Scholar
- Hausdorff JM, Edelberg HK, Mitchell SL, Goldberger AL, Wei JY: Increased gait unsteadiness in community-dwelling elderly fallers. Arch Phys Med Rehabil 1997, 78: 278-283. 10.1016/S0003-9993(97)90034-4View ArticlePubMedGoogle Scholar
- Hausdorff JM, Nelson ME, Kaliton D, Layne JE, Bernstein MJ, Neurnberger A, Singh MAF: Etiology and modification of gait instability in older adults: a randomized controlled trial of exercise. J Appl Physiol 2001, 90: 2117-2129.PubMedGoogle Scholar
- Hausdorff JM, Rios DA, Edelberg HK: Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil 2001, 82: 1050-1056. 10.1053/apmr.2001.24893View ArticlePubMedGoogle Scholar
- Morris ME, Iansek R, Matyas TA, Summers JJ: Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain 1996, 119: 551-568.View ArticlePubMedGoogle Scholar
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166: 111-117.View ArticleGoogle Scholar
- Troosters T, Gosseling R, Decramer M: Six minute walking distance in healthy elderly subjects. Eur Resp 1999, 14: 270-274. 10.1034/j.1399-3003.1999.14b06.xView ArticleGoogle Scholar
- Pankoff BA, Overend TJ, Lucy SD, White KP: Reliability of the six-minute walk test in people with fibromyalgia. Arthritis Care Res 2000, 13: 291-295. Publisher Full Text 10.1002/1529-0131(200010)13:5<291::AID-ANR8>3.0.CO;2-XView ArticlePubMedGoogle Scholar
- Opasich C, Pinna GD, Mazza A, Febo O, Riccardi PG, Capomolla S, Cobelli F, Tavazzi L: Reproducibility of the six-minute walking test in patients with chronic congestive heart failure:practical implications. Am J Cardiol 1998, 15: 1497-1500. 10.1016/S0002-9149(98)00218-5View ArticleGoogle Scholar
- Ghez C, Gordon J, Ghilardi MF: Impairments of reaching movements in patients without proprioception. II. Effects of visual information on accuracy. J Neurophysiol 1995, 73: 361-372.PubMedGoogle Scholar
- Gordon J, Ghilardi MF, Ghez C: Impairments of reaching movements in patients without proprioception I. Spatial errors. J Neurophysiol 1995, 73: 347-360.PubMedGoogle Scholar
- Bard C, Fleury M, Teasdale N, Paillard J, Nougier V: Contribution of proprioception for calibrating and updating the motor space. Can J Physiol Pharmacol 1995, 73: 246-254.View ArticlePubMedGoogle Scholar
- Boecker H, Ceballos-Baumann A, Bartenstein P, Weindl A, Siebner HR, Fassbender T, Munz F, Schwaiger M, Conrad B: Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain 1999, 122: 1651-1665. 10.1093/brain/122.9.1651View ArticlePubMedGoogle Scholar
- Francis ST, Kelly EF, Bowtell R, Dunseath WJ, Folger SE, McGlone F: fMRI of the responses to vibratory stimulation of digit tips. Neuroimage 2000, 11: 188-202. 10.1006/nimg.2000.0541View ArticlePubMedGoogle Scholar
- Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C, Parkinson Study Group: Freezing of gait in PD: prospective assessment in DATATOP cohort. Neurology 2001, 56: 1712-1721.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.